Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MD, Albert Einstein College of Medicine
… → 2016
Fingerprint
Dive into the research topics where Arjun Seth is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 6 Active
-
Prot #ARGX-113-2315: A Randomized, Double-Blinded, Placebo-Controlled, Phase 3, Parallel-Group Design Study Evaluating the Efficacy and Safety of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Ocular Myasthenia Gravis
Seth, A. (PD/PI)
PPD Investigator Services, LLC, arGEN-X BV
3/25/25 → 3/25/28
Project: Research project
-
Prot #ARGX-113-2308: A Randomized, Double-Blinded, Placebo-Controlled, Phase 3, Parallel-Group Design Study Evaluating the Efficacy and Safety of Efgartigimod IV in Adult Participants With Acetylcholine Receptor Binding Antibody Seronegative Generalized
Seth, A. (PD/PI)
PPD Investigator Services, LLC, arGEN-X BV
1/30/25 → 1/30/28
Project: Research project
-
Prot #ARGX-113-2011: A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inf
Seth, A. (PD/PI)
ICON Clinical Research, LLC, arGEN-X BV
2/8/24 → 2/28/27
Project: Research project
-
Prot #ARGX‐113‐2007: A Phase 2/3, Randomized, Double‐Blinded, Placebo‐Controlled, Parallel‐Group, 2‐Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Ef
Seth, A. (PD/PI)
4/25/23 → 4/25/26
Project: Research project
-
A Case Report of Systemic Lupus Erythematosus Presenting as Isolated Mononeuropathy Multiplex
Andreoli, M., Hollenhorst, C. N., Malavia, T., May, J. L., Priyadarshini, S., Seth, A. & Dixit, K., 2024, (Accepted/In press) In: Neurohospitalist.Research output: Contribution to journal › Article › peer-review
Open Access -
Recognizing Myopathy in Patients with Muscle Weakness or Pain
Elafros, M. A. & Seth, A., Jun 2024, In: Primary Care - Clinics in Office Practice. 51, 2, p. 311-326 16 p.Research output: Contribution to journal › Review article › peer-review
-
Tubular aggregate myopathy causing progressive fatiguable weakness
Fan, Q., Gwathmey, K., Du, X., Seth, A. & Corse, A., Nov 3 2023, In: Practical Neurology. 24, 2, p. 137-140 4 p.Research output: Contribution to journal › Article › peer-review
-
Clinical Reasoning: A 68-year-old man with rapid cognitive decline
Berth, S. H., Seth, A., Cohen, A., Rivera Lara, L., Hui, F. & Sun, L. R., Aug 13 2019, In: Neurology. 93, 7, p. 315-318 4 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Scopus citations -
Associations of Biomarker-Calibrated Sodium and Potassium Intakes with Cardiovascular Disease Risk among Postmenopausal Women
Prentice, R. L., Huang, Y., Neuhouser, M. L., Manson, J. E., Mossavar-Rahmani, Y., Thomas, F., Tinker, L. F., Allison, M., Johnson, K. C., Wassertheil-Smoller, S., Seth, A., Rossouw, J. E., Shikany, J., Carbone, L. D., Martin, L. W., Stefanick, M. L., Haring, B. & Van Horn, L., Nov 1 2017, In: American journal of epidemiology. 186, 9, p. 1035-1043 9 p.Research output: Contribution to journal › Article › peer-review
Open Access31 Scopus citations